Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$27,586
+$5,512 QoQ
Shares Held
23
-4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#4,547
of 4,601 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Osbon Capital Management LLC holds $1,893,737 across 9 Drug Manufacturers - General names. LLY ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
3,344 | $1,210,929 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,171 | $278,973 | |
| 3 | JNJ |
Johnson & Johnson
|
705 | $179,048 | |
| 4 | ABBV |
AbbVie Inc.
|
326 | $82,034 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,194 | $68,798 | |
| 6 | PFE |
Pfizer Inc
|
1,341 | $32,291 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
23 | $27,586 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
90 | $11,370 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,586 | 23 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $22,074 | 24 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,792 | 24 | Shares | Sole | 2026-03-16 | |
| No filing history on record for this holder in this stock. | ||||||